262 related articles for article (PubMed ID: 18261269)
1. [A randomized and case-control clinical study on trimebutine maleate in treating functional dyspepsia coexisting with diarrhea-dominant irritable bowel syndrome].
Zhong YQ; Zhu J; Guo JN; Yan R; Li HJ; Lin YH; Zeng ZY
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):899-902. PubMed ID: 18261269
[TBL] [Abstract][Full Text] [Related]
2. The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
Dumitraşcu DL; Stănculete M
Rom J Intern Med; 2006; 44(3):273-80. PubMed ID: 18386606
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome.
Long Y; Liu Y; Tong J; Qian W; Hou X
Eur J Pharmacol; 2010 Jun; 636(1-3):159-65. PubMed ID: 20371236
[TBL] [Abstract][Full Text] [Related]
5. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study].
Kang SH; Jeen YT; Koo JS; Koo YS; Kim KO; Kim YS; Kim SY; Moon JS; Park JJ; Baek IH; Park SC; Lee SJ; Lee JH; Choung RS; Choi SC
Korean J Gastroenterol; 2013 Nov; 62(5):278-87. PubMed ID: 24262593
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY; Lu CL; Chen CY; Luo JC
J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
[TBL] [Abstract][Full Text] [Related]
8. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
Zhao L; Song W; Zhu P; Zhang Y; Bu P
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
[TBL] [Abstract][Full Text] [Related]
9. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
Tegaserod Clinical Research Group
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of trimebutine versus mebeverine in the treatment of irritable bowel syndrome.
Rahman MZ; Ahmed DS; Mahmuduzzaman M; Rahman MA; Chowdhury MS; Barua R; Ishaque SM
Mymensingh Med J; 2014 Jan; 23(1):105-13. PubMed ID: 24584382
[TBL] [Abstract][Full Text] [Related]
11. Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.
Kountouras J; Gavalas E; Papaefthymiou A; Tsechelidis I; Polyzos SA; Bor S; Diculescu M; Jadallah Κ; Tadeusz M; Karakan T; Bochenek Α; Rozciecha J; Dabrowski P; Sparchez Z; Sezgin O; Gülten M; Farsakh NA; Doulberis M
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32650518
[No Abstract] [Full Text] [Related]
12. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
[TBL] [Abstract][Full Text] [Related]
14. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
15. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
[TBL] [Abstract][Full Text] [Related]
16. A case of trimebutine-induced anaphylaxis.
Lee SY; Kim MY; Kang SY; Song WJ; Kang HR
Allergol Int; 2011 Dec; 60(4):555-6. PubMed ID: 22113162
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ
Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL
Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
[TBL] [Abstract][Full Text] [Related]
19. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
Krause R; Ameen V; Gordon SH; West M; Heath AT; Perschy T; Carter EG
Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
